4/23/2014 9:19:47 AM
BAGSVAERD, Denmark, April 23, 2014 (GLOBE NEWSWIRE) -- At Novo Nordisk's Annual General Meeting on 20 March 2014, it was decided to reduce the company's B share capital from DKK 442,512,800 to DKK 422,512,800 by cancellation of part of the company's portfolio of own B shares at a nominal value of DKK 20,000,000 divided into 100,000,000 B shares of DKK 0.20 each.
Help employers find you! Check out all the jobs and post your resume.
comments powered by